Dudediligence.

Allarity Therapeutics, Inc

ALLRNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$0.00Mar ’25$25,000Mar ’26$0.00Jun ’26
Net income, by quarter
−$11.6MSep ’24−$7.5MDec ’24−$2.7MMar ’25−$2.3MJun ’25−$2.8MSep ’25−$3.4MDec ’25−$2.8MMar ’26−$3.4MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenuenone on filenone on filenone on file$0.00$320,000
Gross profitnone on file−$2.3Mnone on filenone on filenone on file
Operating income−$26.6M−$34.5M−$17.1M−$27.2M−$12.6M
Net income−$26.6M−$16.1M−$11.9M−$24.5M−$11.2M
Operating cash flow−$14.9M−$16.8M−$12.7M−$17.4M−$14.8M
Free cash flownone on file−$16.8M−$12.7M−$17.6M−$14.8M
Cash$19.6M$2.0M$166,000$19.5M$14.7M
Debtnone on filenone on file$2.9Mnone on filenone on file
Shares outstanding8.1M11.4K9.8K7.3M16.1M